FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/079899 [Registered on: 03/02/2025] Trial Registered Prospectively
Last Modified On: 03/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Efficacy of garjar beej churn vati in oligohypomenorrhea 
Scientific Title of Study   Randomised controlled clinical study to evaluate the efficacy of Garjar beej churn Vati in artavkshaya with special reference to oligohypomenorrhea 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rani Keshav kadam 
Designation  Pg scholar 
Affiliation  Shree saptshrungi ayurved mahavidyalaya and hospital nashik 
Address  Department of prasutitantra and stree rog Shree Saptashrungi sourced mahavidyala hirawadi kamal nagar Panchavati Nashik 422003

Nashik
MAHARASHTRA
422003
India 
Phone  702733620  
Fax    
Email  kadamrani142@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rani Keshav kadam 
Designation  Pg schlor 
Affiliation  Shree saptshrungi ayurved mahavidyalal and hospital Nashik 
Address  Department of prasutitantra and stree rog shree Saptashrungi ayurved mahavidyalayal and hospital Nashik 422003

Nashik
MAHARASHTRA
422003
India 
Phone  7020733620  
Fax    
Email  kadamrani142@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sunil Sadashiv more 
Designation  Professor and HOD  
Affiliation  Shree saptshrungi ayurved mahavidyala 
Address  OPD no 3 Department of prasuti tantra and stree rog Shree saptshrungi ayurved mahavidyalaya and hospital nashik
OPD no 3 Department of prasuti tantra and stree rog Shree saptshrungi ayurved mahavidyalaya and hospital nashik
Nashik
MAHARASHTRA
422003
India 
Phone  9423934506  
Fax    
Email  moresunil263@gmail.com  
 
Source of Monetary or Material Support  
Shree Saptashrungi Ayurved mahavidyala and hospital Kamal nagar Hirawadi Nashik 422003 
 
Primary Sponsor  
Name  Shree Saptashrungi ayurved mahavidyalay Kamal nagar nashik 420003 
Address  OPD number 23Department of prasutitantra tantra and stree rog Shree saptshrungi ayurved mahavidyalaya and hospital kamal nagar nashik 422003 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rani Keshav kadam  Shree Saptashrungi Ayurved mahavidyala and hospital Kamal nagar nashik  OPD number 3 department of prasutitantra and stree rog Shree Saptashrungi Ayurved mahavidyalaya and hospital Hirawadi kamal nagar Nashik 422003
Nashik
MAHARASHTRA 
7020733620

kadamrani142@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC of Shree saptshrungi ayurved mahavidyalaya and hospital nashik  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N926||Irregular menstruation, unspecified. Ayurveda Condition: ARTAVAKSHAYAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Garjarbeej, Reference: Ayurved Saar sangraha , Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Age group 18 to 35 years
Menstrual duration more than 35 days and menstrual bleeding flow less than 2 days
The interval between two cycles exceeds than 35 days
All female patient who have signed written informed consent
 
 
ExclusionCriteria 
Details  Patient age below 18 years and above 35 years
ANC and PNC patient
Patient having disease related to urogenital system
Patient having uterine pathology like fibroid uterine cyst endometriosis PID
Known case of CA cervix and endometrial CA
Anemia hb less than 8 gm  
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief from symptoms and regulation of menstruation   2-3month 
 
Secondary Outcome  
Outcome  TimePoints 
One month  2 to 3 month 
Regulation of menstruation   2-3month 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   15/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The menstrual cycle which involves the shading of endometrial which was prepared in anticipation of providing a bed for fertilized ovum 
Artavkshaya involves menstrual bleeding that occurs more than 35 days and lasting for 2-3 days
Primary objective 
To study the efficacy of garjar beej churn vati in artavkshaya 
Secondary objective 
To study ayurvedic literature on artavkshsya as per ayurveda
To study modern literature on artavkshsya
To study the preparation of garjar beej churn vati
Participants 
60


Primary outcomes 
Reduce sign and symptoms 
Secondary outcomes 
Regulation of cycles



Patient will be observed before and after treatment. All observations and data Coll after the final assessment will be subjected to statistical analysis as mentioned 

 
Close